A detailed history of Petrus Trust Company, Lta transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Petrus Trust Company, Lta holds 4,342 shares of ANIP stock, worth $235,162. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,342
Previous 3,629 19.65%
Holding current value
$235,162
Previous $231,000 12.12%
% of portfolio
0.03%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$54.33 - $65.72 $38,737 - $46,858
713 Added 19.65%
4,342 $259,000
Q4 2023

Feb 14, 2024

SELL
$48.72 - $65.43 $103,383 - $138,842
-2,122 Reduced 36.9%
3,629 $200,000
Q2 2023

Aug 14, 2023

BUY
$37.29 - $53.83 $214,454 - $309,576
5,751 New
5,751 $309,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $944M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Petrus Trust Company, Lta Portfolio

Follow Petrus Trust Company, Lta and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petrus Trust Company, Lta, based on Form 13F filings with the SEC.

News

Stay updated on Petrus Trust Company, Lta with notifications on news.